Duncan Topliss

Duncan Topliss is Adjunct Professor in the Department of Medicine at Monash University and Director of the Department of Endocrinology and Diabetes at the Alfred Hospital, Melbourne, Australia. He is a leading figure in endocrinology with extensive contributions to clinical research, guidelines, and healthcare policy.

His research interests center on endocrinology and diabetes, particularly the prevention and management of acute and chronic complications of diabetes. He has served as an investigator in major international diabetes trials and has been instrumental in developing Clinical Practice Guidelines (CPGs) for diabetes and endocrine diseases. His work also extends to thyroid cancer, drug regulation and safety, and osteoporosis in transplant patients.

Recent publications highlight a growing focus on thyroid cancer registries and multidisciplinary management of endocrine disorders. His research spans clinical trials, systematic reviews, and public health reporting, often in collaboration with national and international teams.

Scientific Awards and Honors:

• Life Member, Endocrine Society of Australia
• Past-President, Endocrine Society of Australia

Advising and Grants: While specific student names are not listed, Professor Topliss has served as a Principal Chief Investigator on significant research projects, including the LIBRETTO-531 trial on RET-mutant medullary thyroid cancer. His leadership in clinical trials and national registries demonstrates sustained grant funding and mentorship of research teams.

Labs and Teams: He chairs the Drugs and Therapeutics Committee at Alfred Health and is a key member of the Australian Advisory Committees on Medicine Safety and Pharmaceutical Medicines under the Therapeutic Goods Administration. He is also deeply involved in the Australian and New Zealand Thyroid Cancer Registry, contributing to binational efforts in cancer surveillance and quality improvement.